Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection?

J. Kers; S. Florquin

doi:https://doi.org/10.1111/ajt.12402

Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection?

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

The study of Cravedi et al (page 2696) challenges the hypothesis that eosinophils are an essential component of the long-lived plasma cells niche in the bone marrow, and it suggests that the role of eosinophils in long-lived plasma cells survival might be mice strain-dependent

Original language	English
Pages (from-to)	2522-2523
Journal	American Journal of Transplantation
Volume	13
Issue number	10
DOIs	https://doi.org/10.1111/ajt.12402
Publication status	Published - 2013

Access to Document

https://doi.org/10.1111/ajt.12402

Cite this

@article{cea7565f1b5f44ac85446e962a371ea1,

title = "Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection?",

abstract = "The study of Cravedi et al (page 2696) challenges the hypothesis that eosinophils are an essential component of the long-lived plasma cells niche in the bone marrow, and it suggests that the role of eosinophils in long-lived plasma cells survival might be mice strain-dependent",

author = "J. Kers and S. Florquin",

year = "2013",

doi = "https://doi.org/10.1111/ajt.12402",

language = "English",

volume = "13",

pages = "2522--2523",

journal = "American Journal of Transplantation",

issn = "1600-6135",